ǰÑÔ
ÄêËêÏà¹ØÐԻư߱äÐÔ(age related macular degeneralion, AMD)ÊÇ65ËêÒÔÉÏÍíÄêÈËÖÂäµÄÖ÷ÒªÔµ¹ÊÔÓÉ¡£AMD·ÖΪÎÞÐÂÉúѪ¹ÜÌìÉúµÄ¸ÉÐÔÒÔ¼°ÐÂÉúѪ¹ÜÌìÉúµÄʪÐÔÌåÏÖ¡£ÊªÐÔAMD»¼Õß±¬·¢CNVÊǵ¼ÖÂÊÓÁ¦ËðʧµÄ×î³£¼ûÒòËØ¡£±¾Õ½«ÏÈÈÝCNVµÄÔìÄ£ÒªÁì¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î´óÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
ÏÖÔÚÒÔΪ£¬Ç¿¹â»òÕßÒ»Á¬¹â̻¶µ¼ÖµÄÊÓÍøÄ¤ËðÉËÊܵ½ÖÖÊô¡¢ÇøÓò¡¢Òûʳ¡¢¹âËÇÑøÀúÊ·µÄÔ¤´¦Öóͷ£ºÍ»ùÒòÅä¾°µÄÓ°Ïì¡£ÊÓÍøÄ¤Ñõ»¯¹âËðÉ˵ĻúÖÆÖ®Ò»£¬ÊÓÍøÄ¤Ñõ»¯ËðÉ˺͸ÐÊÜÆ÷ϸ°ûËðÉË·´Ó¦ÊÇת¼µ÷Àí¡¢Ã¸»îÐÔµÄת±äºÍ¼¤»î¡¢Ï¸°ûÄÚ½ðÊôÀë×Ó¡¢¶àÖÖµòÍö;¾¶µÈ×ÛÏàÖúÓõÄЧ¹û£¬Í¬Ê±¿ÉÄܱ£´æÖÖÊôÒÀÀµÐÔ¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
ÔÚ¹âÕÕ·½·¨ºÍÇ¿¶ÈÑ¡ÔñÉÏ£¬EsfandiariµÈ֤ʵÃ÷°µ½»ÌæËÇÑø¸üÇкÏÉúÎïµÄÒ»Ñùƽ³£ÉúÑÄ״̬£¬²¢¿É½µµÍ´óÊóÊÓÍøÄ¤ËðÉ˵ÄãÐÖµ£¬Ôì³ÉµÄËðÉ˸üΪÑÏÖØ¡£Ñ¡Ôñ8~9ÖܵijÉÄê´óÊó£¬Ñ¡Ôñ½«´óÊóÖÃÓÚÃ÷°µ½»ÌæÇéÐÎÏÂ˳ӦÐÔËÇÑø1ÖÜ£¬½¨Ä£Ç°ÍêÈ«°µÊÊ12Сʱ£¬ÓÃ(5000±300) luxÇ¿¶È¹âÕÕÉä3Сʱ£¬¿Éµ¼Ö´óÊóÊÓÍøÄ¤ÖØ¶ÈËðÉË¡£Æ¾Ö¤´óÊóµÄÔ˶¯ÌØÕ÷£¬Ôìģʱ¼äѡΪÍí19 : 00ÖÁÔ½ÈÕÔç7: 00¡£
¡¾Ä£×ÓÌØµã¡¿£º
¸øÓè1~3Сʱ¹âÕÕÇ¿¶È(5000±300) luxµÄ¹â·øÕÕ£¬¾ù¿ÉÒÔµ¼ÖÂÊÓÍøÄ¤µçÐÄÀí¹¦Ð§µÄ½µµÍ¡£²î±ðʱ¼ä¹â·øÕÕºó£¬ERG¸÷ÕÉÁ¿Ö¸±êµÄת±äÓë·øÕÕʱ¼äÊÇ·ÇÓйأ¬·øÕÕʱ¼äÔ½³¤£¬¸Ä±äÔ½ÏÔ×Å£¬ËðÉËÔ½ÖØ£¬ÊµÑé¸÷×é¼ä½ÏÁ¿¾ùÓÐÏÔ×ŵÄͳ¼ÆÑ§ÒâÒå¡£Õý³£±ÈÕÕ×é´óÊóÊÓÍøÄ¤×éÖ¯ÇÐÆ¬½á¹¹ÌõÀíÇåÎú£¬¹â¸ÐÊÜÆ÷µÄÍâ½ÚÅÌĤÅÅÁÐÕûÆë¡¢¹æÔò£¬Äں˲ãºÍÍâºË²ãÅÅÁÐϸÃÜ£¬È¾É«Ôȳơ£Ç¿¹â·øÕÕ¶ÔÊÓÍøÄ¤ÓÐÏÔ×ŵÄËðÉË×÷Óã¬ËðÉ˲¿Î»Ö÷ҪλÓÚ´óÊóò¨ÉÏÏóÏÞÇøÓò£¬¹âËðÉËÊÇÒ»¸ö¼¶±ð·´Ó¦£¬²î±ðÇøÓòËðÉËˮƽ²î±ðºÜ´ó¡£¹â·øÕÕºó²î±ðʱ¼äµã£¬ÊÓÍøÄ¤ONL¸÷ÇøÓòºñ¶È·ºÆðÏÔ×Ųî±ð£¨Í¼12-5/ÎÄÄ©²Êͼ12-5)¡£
ͼ12-5 ²î±ð¹âÕÕʱ¼äϵÄÊÓÍøÄ¤ËðÉËÄ£×Ó
×¢£ºA£®²î±ð¹âÕÕʱ¼äÏÂÊÓÍøÄ¤ÐÎ̬ѧ±ÈÕÕ(×400,Scale bar =50µm); B£®²î±ð¹âÕÕʱ¼äϲî±ðÇøÓòÊÓÍøÄ¤ÍâÍø²ãºñ¶Èת±ä(REP£ºÉ«ËØÉÏÆ¤²ã£»OS£º¹â¸ÐÊÜÆ÷Íâ½Ú£»IS£º¹â¸ÐÊÜÆ÷ÄÚ½Ú£»ONL£ºÍâºË²ã£»OPL£ºÍâ´Ô×´²ã£»INL£ºÄں˲㣻 IPL£ºÄÚ´Ô×´²ã£»GCL£ºÉñ¾½Úϸ°û²ã£©
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
¹âËðÉËÊÓÍøÄ¤¼²²¡¶¯ÎïÄ£×Ó£¬ÓÉÓÚÖÖÖÖÔìÄ£×°±¸µÄ²î±ð£¬±¬·¢µÄЧ¹û²»¾¡Ïàͬ¡£ÊµÑéÖÐÒª°ü¹ÜʵÑ鶯ÎïµÄÊÓÍøÄ¤Äܳä·ÖµØ±»¹âÕÕÉ䣻ÔÚ¹âÇ¿µÄÑ¡ÔñÉÏ£¬ÒªÒÔʵÑéÄ¿µÄΪ»ù´¡£¬Ñ¡ÔñºÏÊʵĹâÇ¿£»ÔÚÔìÄ£¶¯ÎïµÄÄêËêÉÏ£¬Òª×¢ÖØÑ¡Ôñ³ÉÄê´óÊó£¬JolyµÈ±¨µÀ¸øÓèÓ×Äê(2ÖÜ»òÕß4ÖÜ£©ºÍ³ÉÄê(8ÖÜ£©´óÊóÒ»ÂɵĹâÕÕÇ¿¶È£¬Ó×ÊóÔâÊܵĹâÕÕËðÉ˽ÏÇᣬµ«ÕâÖÖÓÅÊÆÔÚ4ÖܺóÖð½¥ÏûÊÅ£»²¢ÇÒÔìÄ£ÇéÐεÄζÈÒ²ÊÇÓ°ÏìʵÑéЧ¹ûµÄÖ÷ÒªÒòËØ£¬±¾ÊµÑéÊÒ·¢Ã÷ÔÚ¸ßÎÂʱ»á¼ÓÖØÊÓÍøÄ¤ËðÉË¡£
²Î¿¼ÎÄÏ×£º
1.ÍõÓ¦Àû£¬»ÝÑÓÄ꣮ÌÇÄò²¡ÊÓÍøÄ¤²¡±ä»»ÎïÄ£×ÓÑ¡ÔñµÄ×¢ÖØÊÂÏÖлªÑÛ¿ÆÔÓÖ¾£¬2012,48 (7):587-590
2.Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res,2009,49: 2636-2652
3.Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol, 1938,22(10): 613-623
4.Bundey S,Crews SJ. A study of retinitis pigrnentosa in the city of Birmingham-I. J Med Genet, 1984,21(6):417-420
5.Chang B, Heckenlively IB,Bayley PR.et a.I. The nob2 mouse, a null mutation in Cacnalf: anatomical and functional abnormalities in the outer retina and their consequences on ganglion cell visual responses. Vis Neurosci, 2006, 23 (1): 11-24
6.Criswell MH,Ciulla TA,Hill TE,et al. The squirrelmonkey: characterization of a new-world primate model of xperimental choroidal neovascularizalion and comparison with the macaque. Invest Ophthalmol Vis Sci,2004, 45 (2): 625-634
7.Gu Y, Wang L,Zhou J,et al. A naturally-occurring mutation in CacnaIf in a rat model of congenital stationary night blindness. Mo! Vis,2008, 14(1):20-28
8.Lue CL. Rod cell activity in retinal degenerative rats. J Formos Med Assoc, 1994,93(7):605-610
9.Pinkert CA. Transgenic animal technology. New York: Academic Press, 1994
10.Sato H, Suzuki T, Ikeda K, et aL A monogenic dominant mutation in Rom l generated by N-ethyl-N-nitrosourea mutagenesis causes retinal degeneration in mice. Mol Vis,2010, 16:378-391
11.Williams TP, Howell WL. Action spectrum of retinal light-damage in albino rats. Invest Ophthalmol Vis Sci, 1983, 24 (3):285-287
12.Won J, Shi LY, Hicks W, et al. Mouse model resources for vision research. J Ophthalmol,2011,2011:391384
13.Xie B,Nakanishi S,Guo Q,et al. A novel middlewavelength opsin (M-opsin) null-mutation in the retinal cone dysfunction ral. Exp Eye Res,2010,91(1):26-33